The protein kinase C inhibitor CGP 41251, a staurosporine derivative with antitumor activity, reverses multidrug resistance

Multidrug resistance (MDR) is frequently associated with overexpression of a 170‐kDa P‐glycoprotein (Pgp). Data suggest altered protein kinase C (PKC) activity in cells expressing the multidrug‐resistant phenotype. The staurosporine derivative CCP A1251, an experimental anticancer drug, has been …